Abbott launches first customer experience center in Shanghai
Abbott said it has launched its first customer experience center in Shanghai to boost its in vitro diagnosis business to tap the booming Chinese market and medical demand.
In vitro diagnostics market is worth US$50 billion worldwide and the customer experience center "demonstrates our response to growing and changing healthcare needs around the world as well as our substantial local investment to grow business here," said Brian Blaser, executive vice president of Abbott Diagnostics Products.
China is currently the second largest market for Abbott's diagnostics businesses globally after the United States.
The 5,000-square-meter facility is also close to Abbott's China R&D Center, which will bring the company's research efforts to a full circle by listening to demand from local hospitals and medical institutions. It would also help the company better understand medical professionals' need for diagnostics solutions.
With 25 full-time scientific and technical experts, the customer experience center will offer training and education, customer support and showcasing diagnostics solutions for both existing and potential customers.
Although a significant part of the customers of Abbott's diagnostics service and system are large scale hospitals, the contribution from grassroots medical institutions and healthcare organizations will pick up in the future as China pushes forward its "Healthy China" vision, according to Abbott Diagnostics China vice president Jerry Tu.
"It would be a big trend for medical institutions to adopt scalable and more efficient diagnostics facilities and solutions to raise testing and operation efficiency," he added.
